image
PainReform Ltd. PRFX
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL
Watchlist
$ 0.5308
-0.226 %
$ 1.18 M
Market Cap
-0.02
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% -6.28% -8.06%
Annual Report FY 10-K 2022-12-31 0.00% -21.34% -23.04%
Annual Report FY 10-K 2021-12-31 0.00% -78.78% -331.36%
Annual Report FY 10-K 2020-12-31 0.00% -122.69% -142.53%
Annual Report FY 10-K 2019-12-31 0.00% -119.81% -37.80%
Annual Report FY 10-K 2018-12-31 0.00% 60.38% 43.18%
Annual Report FY 10-K 2017-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2024-06-30 0.00% -235.26% -226.15%
Quarterly Report Q1 8-K 2024-03-31 0.00% -150.61% -130.34%
Quarterly Report Q4 8-K 2023-12-31 0.00% -55.52% -9.46%
Quarterly Report Q3 8-K 2023-09-30 0.00% 101.70% 35.50%
Quarterly Report Q2 8-K 2023-06-30 0.00% -22.12% -22.06%
Quarterly Report Q1 8-K 2023-03-31 0.00% -29.69% -44.50%
Quarterly Report Q4 8-K 2022-12-31 0.00% -81.48% -87.02%
Quarterly Report Q3 8-K 2022-09-30 0.00% -19.82% -18.55%
Quarterly Report Q2 8-K 2022-06-30 0.00% -5.00% -11.14%
Quarterly Report Q1 8-K 2022-03-31 0.00% 17.00% 18.00%
Quarterly Report Q4 8-K 2021-12-31 0.00% -73.13% -151.95%
Quarterly Report Q3 8-K 2021-09-30 0.00% -62.63% -152.57%
Quarterly Report Q2 8-K 2021-06-30 0.00% -155.02% -1021.62%
Quarterly Report Q1 8-K 2021-03-31 0.00% -57.48% -1444.70%
Quarterly Report Q4 8-K 2020-12-31 0.00% -39.61% -208.48%
Quarterly Report Q3 8-K 2020-09-30 0.00% -51.88% -212.50%
Quarterly Report Q2 8-K 2020-06-30 0.00% -36.82% -22.82%
Quarterly Report Q1 8-K 2020-03-31 0.00% -165.85% -9.54%
Quarterly Report Q4 8-K 2019-12-31 0.00% -51.11% -84.36%
Quarterly Report Q3 8-K 2019-09-30 0.00% -51.11% -84.36%
Quarterly Report Q2 8-K 2019-06-30 0.00% -5.41% 6.23%
Quarterly Report Q1 8-K 2019-03-31 0.00% -5.41% 6.23%
Quarterly Report Q4 8-K 2018-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2018-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2018-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2018-03-31 0.00% 0.00% 0.00%